{"disease":{"id":"hematologic-disorders","name":"hematologic disorders"},"drugs":{"marketed":[{"drug_id":"sodium-succinate","indication_name":"Hematologic Disorders","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SODIUM SUCCINATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00001620","title":"Screening for Hematology Branch Protocols","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT03342495","title":"Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT07023692","title":"Visual and Auditory Distraction for the Relief of Pain and Anxiety","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT00059423","title":"Natural History Study for BEN","phase":"","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07519811","title":"LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT03093844","title":"Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University of Colorado, Denver","has_results":true},{"nct_id":"NCT04235153","title":"CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06271252","title":"A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":81,"lead_sponsor_name":"OriCell Therapeutics Co., Ltd.","has_results":false},{"nct_id":"NCT01787552","title":"A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07200583","title":"Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Ting YANG","has_results":false},{"nct_id":"NCT07483385","title":"Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"The General Hospital of Western Theater Command","has_results":false},{"nct_id":"NCT02179359","title":"Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies","phase":"NA","overall_status":"TERMINATED","enrollment_count":38,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT04723706","title":"Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients","phase":"","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT05675943","title":"Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in Patients With Hematological Disorders Who Are Persistently Positive for COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Beijing Boren Hospital","has_results":false},{"nct_id":"NCT04309084","title":"Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"Celularity Incorporated","has_results":false},{"nct_id":"NCT03876301","title":"Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03013439","title":"Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Pharmacosmos A/S","has_results":false},{"nct_id":"NCT04631211","title":"Thrombosomes® in Bleeding Thrombocytopenic Patients Study","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"Cellphire Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02130882","title":"Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06828796","title":"Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Northside Hospital, Inc.","has_results":false},{"nct_id":"NCT03048344","title":"A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Orsenix LLC","has_results":false},{"nct_id":"NCT03030248","title":"Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Medical College of Wisconsin","has_results":true},{"nct_id":"NCT03367546","title":"Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT03734588","title":"Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03615144","title":"TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT01881334","title":"Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Joanne Kurtzberg, MD","has_results":false}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}